TG and neoplasm: The AAbs-mediated interference in immunochemical assays was also described for circulating tumor markers CA-15.3 [33], CA-125 [34,35], and, most importantly, for thyroglobulin (TG), a tumor marker of DTC recurrence following primary treatment (see Section 4.2).